0001841613-21-000004.txt : 20210414 0001841613-21-000004.hdr.sgml : 20210414 20210414123636 ACCESSION NUMBER: 0001841613-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210414 DATE AS OF CHANGE: 20210414 EFFECTIVENESS DATE: 20210414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ventus Therapeutics U.S., Inc. CENTRAL INDEX KEY: 0001794785 IRS NUMBER: 834463726 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-395752 FILM NUMBER: 21825112 BUSINESS ADDRESS: STREET 1: 100 BEAVER STREET, SUITE 202 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 415-260-7371 MAIL ADDRESS: STREET 1: 100 BEAVER STREET, SUITE 202 CITY: WALTHAM STATE: MA ZIP: 02453 D 1 primary_doc.xml X0708 D LIVE 0001794785 Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Waltham MA MASSACHUSETTS 02453 415-260-7371 DELAWARE None None Corporation true 2019 Marcelo Bigal c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Executive Officer Director Jerel Davis c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Director Brendan Bulik-Sullivan c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Director Daniel Koerwer c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Executive Officer Zachary McNealy c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Executive Officer Josh Resnick c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Director Steven James c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Walthum MA MASSACHUSETTS 02453 Director Michael Crackower c/o Ventus Therapeutics U.S., Inc. 100 Beaver Street, Suite 202 Waltham MA MASSACHUSETTS 02453 Executive Officer Biotechnology Decline to Disclose 06b false 2021-03-31 false true false 0 99999989 99999989 0 false 17 0 0 0 false Ventus Therapeutics U.S., Inc. /s/ Zachary McNealy Zachary McNealy Chief Financial Officer 2021-04-13